BetaEntity Annotation Prototype

Entity family

Browse treatments

Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.

7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed

All extracted treatments

Showing 2,821–2,880 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.

alternative treatment options1ambulatory oxygen therapy1amyloid-clearing therapies1anaesthetics1analgesic strategies1androgen receptor inhibitors1aneurysm embolization1angioplasty and stenting1angiotensin II receptor blocker1anteroseptal line ablation1anthracycline-based therapy1anti- H.pylori treatment1anti-CD19 CAR-T therapy1anti-CD20 therapies1anti-CGRP therapies1anti-CTLA4 therapy1anti-HER2 therapies1anti-HER2 therapy1anti-IL5R therapy1anti-PD therapy1anti-PD-(L)1 therapy1anti-PD-1 therapies1anti-PD-1/PD-L1 therapies1anti-TB therapy1anti-TNF treatment1anti-TNF-α therapy1anti-TNFα treatment1anti-aTNF therapy1anti-amyloid immunotherapy1anti-amyloid monoclonal antibody therapies1anti-cancer interventions1anti-cancer treatments1anti-eosinophilic biologic therapy1anti-fibrinolytic treatment1anti-fungal induction therapy1anti-hypertensives1anti-infective therapy1anti-infective treatment1anti-inflammation1anti-inflammatory analgesia1anti-inflammatory diet1anti-inflammatory strategies1anti-inflammatory-based management1anti-interleukin-1 therapy1anti-metabolite therapy1anti-metastatic therapies1anti-osteoporotic medication1anti-programmed cell death ligand-1(PD-L1) therapy1anti-programmed cell death protein 1 (PD-1) therapy1anti-programmed cell death protein 1 ICB1anti-programmed cell death protein 1 immunotherapy1anti-programmed cell death protein-1 (PD-1) therapy1anti-programmed cell death-ligand 1 immunotherapy1anti-programmed death-ligand 1 therapy1anti-pyretics1anti-reflux therapy1anti-rejection medication1anti-rejection medications1anti-respiratory syncytial virus (RSV) antibody prophylaxis1anti-rheumatic therapy1

Articles mentioning treatments

7,227 articles · page 104 of 603
vasodilator therapyimmunosuppressive therapymycophenolate mofetilmethotrexatetocilizumabazathioprinetacrolimusleflunomidecyclophosphamiderituximab+3 more

…Sc) and, despite significant advances, still responds poorly to vasodilator therapy. Histopathological and experimental data suggest an immune-medi…

CD19-targeting CAR T cell therapyfludarabinecyclophosphamideUniversity hospital Erlangenautoimmune diseasesCD19-targeting CAR T cells

…evelopment of GI symptoms in eight SSc patients after receiving CD19-targeting CAR T cell therapy.Material and Methods CD19-targeting CAR T cells were acquired a…

CAB/RPVcabotegravir/rilpivirineS.M. Goretti Hospitalgeneralized anxiety disorderHIVSant’Andrea University Hospital Infectious Diseases ClinicsPWHPatient Health Questionnaire-9Generalized Anxiety Disorder-7

… moderately accepted by PWH, that can highlight serious issues. CAB/RPV continues to be a highly valued therapy even after 2 years of t…

Semirigid thoracoscopypleural diseasesNCT06741839China-Japan Friendship Hospital Ethics Committee

…Introduction Semirigid thoracoscopy plays an important role in the diagnosis of pleural diseases. H…

PTAStertiary care centerASILsAcute silent ischemic lesions (ASILs)Preprocedural ASILssevere intracranial stenosissevere sICAS

…SILs were independently associated with inhospital stroke after PTAS in patients with severe sICAS. Incorporation of ASIL status int…